Latest Articles
Will CRVL stock reach Wall Street targets - 2025 Technical Overview & Safe Entry Trade Signal Reports - newser.com
Will CRVL stock reach Wall Street targets - 2025 Technical Overview & Safe Entry Trade Signal Reports newser.com
Published: Sept. 26, 2025, 3:33 p.m.
How reliable is Baker Hughes Company (68V) stock dividend growth - July 2025 Opening Moves & Fast Gaining Stock Reports - newser.com
How reliable is Baker Hughes Company (68V) stock dividend growth - July 2025 Opening Moves & Fast Gaining Stock Reports newser.com
Published: Sept. 26, 2025, 2:29 p.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com Australia
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com Australia
Published: Sept. 26, 2025, 11:03 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com South Africa
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com South Africa
Published: Sept. 26, 2025, 10:56 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com India
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com India
Published: Sept. 26, 2025, 10:48 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com
Published: Sept. 26, 2025, 10:25 a.m.
Deep infiltrating endometriosis: retroperitoneal endometriosis-a case report - BMC Women's Health
Deep infiltrating endometriosis: retroperitoneal endometriosis-a case report BMC Women's Health
Published: Sept. 26, 2025, 10:06 a.m.
From gut to gamete: how the microbiome influences fertility and preconception health - BioMed Central
From gut to gamete: how the microbiome influences fertility and preconception health BioMed Central
Published: Sept. 26, 2025, 7:05 a.m.
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Non-Hormonal Endometriosis Therapy.
Previous studies show that orphan nuclear receptor 4A1 (NR4A1) regulated endometriotic cell growth, survival, estrogen receptor β (ERβ), mTOR signaling and fibrosis. NR4A2 is also expressed in epithelial and stromal …
Published: Sept. 26, 2025, midnight
Endometriosis Diagnostic Delay and Its Correlates: Results from the ComPaRe-Endometriosis Cohort.
Background: An average time to diagnosis of 7 years is commonly described for endometriosis; diagnostic delay for adenomyosis is unknown. This cross-sectional study aimed to describe diagnostic delay for endometriosis …
Published: Sept. 26, 2025, midnight
Link copied to clipboard!